SFO
MRTX

Standard Family Office’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Standard Family Office’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-307
Closed -$67K – 671
2020
Q4 		$67K Buy
+307
New +$67K 0.02% 235